Advocating for Enhanced Pharmaceutical Accountability

This chapter discusses the need for pharmaceutical companies to undertake thorough long-term studies on drug safety. It highlights the push for legislative reforms to better regulate the industry and ensure patient safety, particularly concerning iatrogenic harm.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.